P047 The bi-specific T-cell enhancer (BiTE) MT103 (MEDI-538) shows clinical activity in pre-treated NHL: update from the ongoing Phase I study MT103-104
G. Zugmaier, A. Viardot, G. Hess, R. Noppeney, P. Kufer, E. Leo, D. Reitsma, M. Goebeler, S. Knop, H. Einsele, R. BargouVolume:
31
Year:
2007
Language:
english
Pages:
1
DOI:
10.1016/s0145-2126(07)70395-8
File:
PDF, 103 KB
english, 2007